Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 19.

Eckers, F; Bauer, D E; Hingsammer, A; Sutter, R; Brand, B; Viehöfer, A; Wirth, S H (2018). Mid- to long-term results of total ankle replacement in patients with haemophilic arthropathy: A 10-year follow-up. Haemophilia, 24(2):307-315.

Ernstbrunner, Lukas; Hingsammer, Andreas M; Catanzaro, Sabrina; Sutter, Reto; Brand, B; Wieser, Karl; Fucentese, Sandro F (2017). Long-term results of total knee arthroplasty in haemophilic patients: an 18-year follow-up. Knee Surgery, Sports Traumatology, Arthroscopy, 25(11):3431-3438.

Kimmich, Nina; Brand, B; Hustinx, H; Komarek, A; Zimmermann, R (2016). Management of anti-colton(a) alloimmunisation in pregnancy: a case report. Transfusion medicine, 26(2):150-152.

Brand, B; Dunn, S; Kulkarni, R (2015). Challenges in the management of haemophilia on transition from adolescence to adulthood. European Journal of Haematology, 95(S81):30-35.

Chowdary, P; Lethagen, S; Friedrich, U; Brand, B; Hay, C; Abdul Karim, F; Klamroth, R; Knoebl, P; Laffan, M; Mahlangu, J; Miesbach, W; Daalsgaard Nielsen, J; Martin-Salces, M; Angchaisuksiri, P (2015). Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial. Journal of Thrombosis and Haemostasis, 13(5):743-754.

Santagostino, E; Lentz, SR; Misgav, M; Brand, B; Chowdary, P; Savic, A; Kilinc, Y; Amit, Y; Amendola, A; Solimeno, LP; Saugstrup, T; Matytsina, I (2015). Safety and efficacy of turoctocog alfa (NovoEight®) during surgery in patients with haemophilia A: results from the multinational guardian™ clinical trials. Haemophilia, 21(1):34-40.

Sandrock-Lang, K; Oldenburg, J; Wiegering, V; Halimeh, S; Santoso, S; Kurnik, K; Fischer, L; Tsakiris, D A; Sigl-Kraetzig, M; Brand, B; Bührlen, M; Kraetzer, K; Deeg, N; Hund, M; Busse, E; Kahle, A; Zieger, B (2015). Characterisation of patients with Glanzmann thrombasthenia and identification of 17 novel mutations. Thrombosis and Haemostasis, 113(4):782-791.

Kerlin, B; Brand, B; Inbal, A; Halimeh, S; Nugent, D; Lundblad, M; Tehranchi, R (2014). Pharmacokinetics of recombinant factor XIII at steady state in patients with congenital factor XIII A-subunit deficiency. Journal of Thrombosis and Haemostasis, 12(12):2038-2043.

Biswas, A; Ivaskevicius, V; Thomas, A; Varvenne, M; Brand, B; Rott, H; Haussels, I; Ruehl, H; Scholz, Ute; Klamroth, R; Oldenburg, J (2014). Eight novel F13A1 gene missense mutations in patients with mild FXIII deficiency: in silico analysis suggests changes in FXIII-A subunit structure/function. Annals of Hematology, 93(10):1665-1676.

Stein, P; Bosshart, M; Brand, B; Schlicker, A; Spahn, D R; Bettex, D (2014). Dabigatran anticoagulation and Stanford type A aortic dissection: lethal coincidence: Case report with literature review. Acta anaesthesiologica Scandinavica, 58(5):630-637.

Lentz, S R; Misgav, M; Ozelo, M; Salek, S Z; Veljkovic, D; Recht, M; Cerquira, M; Tiede, A; Brand, B; Mancuso, M E; Seremetis, S; Lindblom, A; Martinovic, U (2013). Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy. Haemophilia, 19(5):691-697.

Lane, J; et al; Brand, B (2013). A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A. Human Molecular Genetics, 22(9):1903-1910.

Tiede, A; Brand, B; Fischer, R; Kavakli, K; Lentz, S R; Matsushita, T; Rea, C; Knobe, K; Viuff, D (2013). Enhancing the pharmacokinetic properties of recombinant factor VIII: first-in-human trial of glycoPEGylated recombinant factor VIII in patients with hemophilia A. Journal of Thrombosis and Haemostasis, 11(4):670-678.

Brand, B; Graf, L (2012). Neue Antikoagulantien - die direkten Thrombininhibitoren. Therapeutische Umschau. Revue thérapeutique, 69(11):643-649.

Zingg, P O; Fucentese, S F; Lutz, W; Brand, B; Mamisch, N; Koch, P P (2012). Haemophilic knee arthropathy: long-term outcome after total knee replacement. Knee Surgery, Sports Traumatology, Arthroscopy, 20(12):2465-2470.

Reidy, K; Brand, B; Jost, B (2010). Severe elbow arthropathy in a patient with congenital afibrinogenemia: a case report. Journal of Bone and Joint Surgery. American Volume, 92(2):456-458.

Tiede, A; Huth-Kühne, A; Oldenburg, J; Grossmann, R; Geisen, U; Krause, M; Brand, B; Alberio, L; Klamroth, R; Spannagl, M; Knöbl, P (2009). Immunosuppressive treatment for acquired haemophilia: current practice and future directions in Germany, Austria and Switzerland. Annals of Hematology, 88(4):365-370.

Ulrich, S; Brand, B; Speich, R; Oldenburg, J; Asmis, L (2008). Congenital hypersensitivity to vitamin K antagonists due to FIX propeptide mutation at locus -10: a (not so) rare cause of bleeding under oral anticoagulant therapy in Switzerland. Swiss Medical Weekly, 138(7-8):100-107.

Fleisch, F; Reinhart, W H; Brand, B; Berger, C (2005). Epstein-Barr virus DNA in serum in a HIV-infected patient during development and treatment of non-Hodgkin's lymphoma. Swiss Medical Weekly, 135(17-18):263-265.

This list was generated on Wed Jun 19 22:08:46 2019 CEST.